IFLR1000

Ablynx €100 million convertible bonds issue

20/5/2015
Convertible and hybrid securities, Private placement of bonds/notes
Select tab

€ 100 million

$ 111 million

Completed

20/5/2015

Overview:

  • Belgian pharmaceutical company Ablynx has issued €100 million in convertible bonds.
  • The proceeds are going to be used to fund research on experimental drugs.
  • The five year bonds will be issued to qualified investors.
  • JPMorgan Securities and BofA Merrill Lynch were joint bookrunners.

Kurt Stumpo - Journalist

Jurisdiction:

Belgium

Deal types:

Convertible and hybrid securities
Private placement of bonds/notes

Practice area:

Capital markets : Debt

Governing law:

Belgium

Industry sector:

Pharmaceuticals and life sciences

Firms:
Baker McKenzie

Party: Ablynx (Issuer)

Clifford Chance

Party: JPMorgan Securities (Bookrunner)

Party: BofA Merrill Lynch (Bookrunner)

Eubelius

Party: Ablynx (Issuer)

Lawyers: Erwin Destuyver, Lars Van Bever

Related deals